Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Garcia del Muro, X.
  • Maroto, P.
  • Terrasa, J.
  • Castellano, D.
  • Bastus, R.
  • Guma, J.
  • Sagastibeltza, N.
  • Duran, I
  • Ochenduszko, S.
  • Meana, J. A.
  • Garcia-Sanchez, J.
  • Arranz, J. A.
  • Germa, J. R.

Grupos

Abstract

Active surveillance (AS) and adjuvant chemotherapy (AC) with carboplatin are valid alternatives for managing stage I seminoma, and most relapses can be cured with cisplatin-based chemotherapy. However, some reports suggest that AC may modify the classical pattern of recurrences.

Datos de la publicación

ISSN/ISSNe:
1699-048X, 1699-3055

Clinical & Translational Oncology  SPRINGER INT PUBL AG

Tipo:
Article
Páginas:
58-64
PubMed:
32462393
Factor de Impacto:
0,764 SCImago
Cuartil:
Q2 SCImago

Citas Recibidas en Web of Science: 12

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Adjuvant chemotherapy, Relapses, Seminoma, Surveillance

Campos de Estudio

Cita

Compartir